Hodgkin lymphoma

Hodgkin lymphoma is a type of lymphoma (a cancer originating from white blood cells called lymphocytes) characterised by the presence of a type of cell called the ReedSternberg cell. Symptoms include enlargement of lymph nodes, spleen or other immune tissue.

Latest Research and Reviews

Research
27 June 2022 | Open Access

Tyramide-conjugated DNA barcodes enable signal amplification for multiparametric CODEX imaging

Tyramide-conjugated DNA barcodes can be used to perform CODEX imaging without modifying primary antibodies and could complement existing CODEX workflows for multiplexed imaging.
- Paul D. Simonson
- , Itzel Valencia
- & Sanjay S. Patel
Communications Biology 5, 627
Research
21 June 2022 | Open Access

The third-generation anti-CD30 CAR T-cells specifically homing to the tumor and mediating powerful antitumor activity
- Shangkun Zhang
- , Chaojiang Gu
- & Tongcun Zhang
Scientific Reports 12, 10488
Research | 12 April 2022

The outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent years
- Ali Bazarbachi
- , Ariane Boumendil
- & Anna Sureda
Leukemia 36, 1646-1653
Research
16 February 2022 | Open Access

3D analyses reveal T cells with activated nuclear features in T-cell/histiocyte-rich large B-cell lymphoma
- Aresu Sadeghi Shoreh Deli
- , Sonja Scharf
- & Sylvia Hartmann
Modern Pathology, 1-8
Research
28 January 2022 | Open Access

Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?
- Rebecca L. King
- , Alia Gupta
- & Sameer A. Parikh
Blood Cancer Journal 12, 18
Research
01 December 2021 | Open Access

Prognostic value of baseline metabolic tumour volume in advanced-stage Hodgkin’s lymphoma
- Pierre Pinochet
- , Edgar Texte
- & Stéphanie Becker
Scientific Reports 11, 23195

All Research & Reviews

News and Comment

Correspondence | 29 November 2021

Maximum-tolerated dose of lomustine used in combination with etoposide and cyclophosphamide in conditioning regimen for hematopoietic stem cell transplantation in lymphoma patients
- Christianne Tolêdo de Souza Leal
- , Luciano José Megale Costa
- & Abrahão Elias Hallack Neto
Bone Marrow Transplantation 57, 309-311
Correspondence | 09 June 2021

Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomas
- Francesca Bonifazi
- , Irene Defrancesco
- & Mario Arpinati
Bone Marrow Transplantation 56, 2295-2298
Correspondence
11 May 2021 | Open Access

Conditional relative survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma in the Netherlands
- Hidde L. A. Posthuma
- , Josée M. Zijlstra
- & Avinash G. Dinmohamed
Blood Cancer Journal 11, 87
Research Highlights | 04 August 2020

CAR T cells are active in Hodgkin lymphoma
- David Killock
Nature Reviews Clinical Oncology 17, 592
Correspondence | 07 July 2020

Can we cure refractory Hodgkin’s lymphoma with transplantation?
- Stefan O. Ciurea
- , Piyanuch Kongtim
- & Anca Colita
Bone Marrow Transplantation 56, 278-281
Correspondence
21 November 2019 | Open Access

Precise detection of genomic imbalances at single-cell resolution reveals intra-patient heterogeneity in Hodgkin’s lymphoma
- Chiara Mangano
- , Alberto Ferrarini
- & Nicolò Manaresi
Blood Cancer Journal 9, 92

All News & Comment

Hodgkin lymphoma

Latest Research and Reviews

Tyramide-conjugated DNA barcodes enable signal amplification for multiparametric CODEX imaging

The third-generation anti-CD30 CAR T-cells specifically homing to the tumor and mediating powerful antitumor activity

The outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent years

3D analyses reveal T cells with activated nuclear features in T-cell/histiocyte-rich large B-cell lymphoma

Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?

Prognostic value of baseline metabolic tumour volume in advanced-stage Hodgkin’s lymphoma

News and Comment

Maximum-tolerated dose of lomustine used in combination with etoposide and cyclophosphamide in conditioning regimen for hematopoietic stem cell transplantation in lymphoma patients

Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomas

Conditional relative survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma in the Netherlands

CAR T cells are active in Hodgkin lymphoma

Can we cure refractory Hodgkin’s lymphoma with transplantation?

Precise detection of genomic imbalances at single-cell resolution reveals intra-patient heterogeneity in Hodgkin’s lymphoma

Quick links

Discover content

Publishing policies

Author & Researcher services

Libraries & institutions

Advertising & partnerships

Career development

Regional websites

Legal & Privacy

Hodgkin lymphoma

Latest Research and Reviews

News and Comment

Search

Quick links